Literature DB >> 8112306

Role for poliovirus protease 2A in cap independent translation.

A J Macadam1, G Ferguson, T Fleming, D M Stone, J W Almond, P D Minor.   

Abstract

Viral protein synthesis in poliovirus infected cells was found to be influenced by mutations in part of the viral 5'-non-coding region (NCR) in a temperature dependent manner. At elevated temperatures these mutations resulted in virus titre reductions that allowed selection of revertant viruses. Some revertants were found to have retained the 5'-NCR mutations but had compensating mutations in the 2A protease gene that were responsible for the suppression of the temperature sensitive phenotypes. The mutations in 2A enhanced viral protein synthesis at a stage when cap dependent translation was already abolished, suggesting that the virally encoded protein 2A is directly involved in the process of cap independent translation in addition to its role in abolishing cap dependent translation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8112306      PMCID: PMC394893          DOI: 10.1002/j.1460-2075.1994.tb06336.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  20 in total

1.  The molecular biology of poliovaccines.

Authors:  P D Minor
Journal:  J Gen Virol       Date:  1992-12       Impact factor: 3.891

2.  New model for the secondary structure of the 5' non-coding RNA of poliovirus is supported by biochemical and genetic data that also show that RNA secondary structure is important in neurovirulence.

Authors:  M A Skinner; V R Racaniello; G Dunn; J Cooper; P D Minor; J W Almond
Journal:  J Mol Biol       Date:  1989-05-20       Impact factor: 5.469

3.  Nucleotide sequence of a neurovirulent variant of the type 2 oral poliovirus vaccine.

Authors:  S R Pollard; G Dunn; N Cammack; P D Minor; J W Almond
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

4.  Differences in replication of attenuated and neurovirulent polioviruses in human neuroblastoma cell line SH-SY5Y.

Authors:  N La Monica; V R Racaniello
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

5.  Synthesis of infectious poliovirus RNA by purified T7 RNA polymerase.

Authors:  S van der Werf; J Bradley; E Wimmer; F W Studier; J J Dunn
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

6.  A common RNA recognition motif identified within a defined U1 RNA binding domain of the 70K U1 snRNP protein.

Authors:  C C Query; R C Bentley; J D Keene
Journal:  Cell       Date:  1989-04-07       Impact factor: 41.582

7.  The effect of sequences in the 5' non-coding region on the replication of polioviruses in the human gut.

Authors:  P D Minor; G Dunn
Journal:  J Gen Virol       Date:  1988-05       Impact factor: 3.891

8.  Involvement of the 24-kDa cap-binding protein in regulation of protein synthesis in mitosis.

Authors:  A M Bonneau; N Sonenberg
Journal:  J Biol Chem       Date:  1987-08-15       Impact factor: 5.157

9.  Viral cysteine proteases are homologous to the trypsin-like family of serine proteases: structural and functional implications.

Authors:  J F Bazan; R J Fletterick
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

10.  Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA.

Authors:  J Pelletier; N Sonenberg
Journal:  Nature       Date:  1988-07-28       Impact factor: 49.962

View more
  35 in total

1.  A selection system for functional internal ribosome entry site (IRES) elements: analysis of the requirement for a conserved GNRA tetraloop in the encephalomyocarditis virus IRES.

Authors:  M E Robertson; R A Seamons; G J Belsham
Journal:  RNA       Date:  1999-09       Impact factor: 4.942

2.  Mapping the genetic determinants of pathogenicity and plaque phenotype in swine vesicular disease virus.

Authors:  T Kanno; D Mackay; T Inoue; G Wilsden; M Yamakawa; R Yamazoe; S Yamaguchi; J Shirai; P Kitching; Y Murakami
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

3.  Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion.

Authors:  J Martín; G Dunn; R Hull; V Patel; P D Minor
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

4.  Competitive translation efficiency at the picornavirus type 1 internal ribosome entry site facilitated by viral cis and trans factors.

Authors:  Elena Y Dobrikova; Rachel N Grisham; Constanze Kaiser; Jennifer Lin; Matthias Gromeier
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

5.  Recognition of picornavirus internal ribosome entry sites within cells; influence of cellular and viral proteins.

Authors:  L O Roberts; R A Seamons; G J Belsham
Journal:  RNA       Date:  1998-05       Impact factor: 4.942

6.  Defective RNA replication by poliovirus mutants deficient in 2A protease cleavage activity.

Authors:  S F Yu; P Benton; M Bovee; J Sessions; R E Lloyd
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

7.  Cleavage of Poly(A)-binding protein by coxsackievirus 2A protease in vitro and in vivo: another mechanism for host protein synthesis shutoff?

Authors:  V Kerekatte; B D Keiper; C Badorff; A Cai; K U Knowlton; R E Rhoads
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

Review 8.  RNA-protein interactions in regulation of picornavirus RNA translation.

Authors:  G J Belsham; N Sonenberg
Journal:  Microbiol Rev       Date:  1996-09

9.  An attenuating mutation in the 2A protease of swine vesicular disease virus, a picornavirus, regulates cap- and internal ribosome entry site-dependent protein synthesis.

Authors:  Y Sakoda; N Ross-Smith; T Inoue; G J Belsham
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

10.  Poliovirus chimeras replicating under the translational control of genetic elements of hepatitis C virus reveal unusual properties of the internal ribosomal entry site of hepatitis C virus.

Authors:  H H Lu; E Wimmer
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.